Laura Heller

Laura Heller is a Senior Scientist at Nuvation Bio since May 2022, with prior experience as a Toxicology Study Manager at Ovid Therapeutics, where responsibilities included executing toxicology studies and ensuring compliance with regulatory standards. Laura has served as a Study Director at Champions Oncology, Inc., managing pre-clinical drug development studies and coordinating client interactions. A former Fellow at Avalere Health, Laura authored reports on regulatory updates and conducted extensive research on healthcare issues. Academic credentials include a Ph.D. in Chemistry from Georgetown University, where Laura published multiple papers and mentored students, and a B.A. in Chemistry and Art History from Franklin & Marshall College.